Global Dolutegravir Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Dolutegravir Industry Forecast” looks at past sales and reviews total world Dolutegravir sales in 2022, providing a comprehensive analysis by region and market sector of projected Dolutegravir sales for 2023 through 2029. With Dolutegravir sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dolutegravir industry.
This Insight Report provides a comprehensive analysis of the global Dolutegravir landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dolutegravir portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Dolutegravir market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dolutegravir and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dolutegravir.
The global Dolutegravir market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Dolutegravir is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Dolutegravir is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Dolutegravir is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Dolutegravir players cover ViiV Healthcare (GSK), Shanghai Desano Pharmaceuticals, Mylan, Aurobindo Pharma, LAURUS Labs and Adcock Ingram Limited, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Dolutegravir market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Dolutegravir market?
What factors are driving Dolutegravir market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Dolutegravir market opportunities vary by end market size?
How does Dolutegravir break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Dolutegravir Industry Forecast” looks at past sales and reviews total world Dolutegravir sales in 2022, providing a comprehensive analysis by region and market sector of projected Dolutegravir sales for 2023 through 2029. With Dolutegravir sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Dolutegravir industry.
This Insight Report provides a comprehensive analysis of the global Dolutegravir landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Dolutegravir portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Dolutegravir market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Dolutegravir and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Dolutegravir.
The global Dolutegravir market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Dolutegravir is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Dolutegravir is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Dolutegravir is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Dolutegravir players cover ViiV Healthcare (GSK), Shanghai Desano Pharmaceuticals, Mylan, Aurobindo Pharma, LAURUS Labs and Adcock Ingram Limited, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Dolutegravir market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- 10mg Tablets
- 50mg Tablets
- Prevent HIV Infection Following Potential Exposure
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- ViiV Healthcare (GSK)
- Shanghai Desano Pharmaceuticals
- Mylan
- Aurobindo Pharma
- LAURUS Labs
- Adcock Ingram Limited
What is the 10-year outlook for the global Dolutegravir market?
What factors are driving Dolutegravir market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Dolutegravir market opportunities vary by end market size?
How does Dolutegravir break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Dolutegravir Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Dolutegravir by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Dolutegravir by Country/Region, 2018, 2022 & 2029
2.2 Dolutegravir Segment by Type
2.2.1 10mg Tablets
2.2.2 50mg Tablets
2.3 Dolutegravir Sales by Type
2.3.1 Global Dolutegravir Sales Market Share by Type (2018-2023)
2.3.2 Global Dolutegravir Revenue and Market Share by Type (2018-2023)
2.3.3 Global Dolutegravir Sale Price by Type (2018-2023)
2.4 Dolutegravir Segment by Application
2.4.1 Prevent HIV Infection Following Potential Exposure
2.4.2 Other
2.5 Dolutegravir Sales by Application
2.5.1 Global Dolutegravir Sale Market Share by Application (2018-2023)
2.5.2 Global Dolutegravir Revenue and Market Share by Application (2018-2023)
2.5.3 Global Dolutegravir Sale Price by Application (2018-2023)
3 GLOBAL DOLUTEGRAVIR BY COMPANY
3.1 Global Dolutegravir Breakdown Data by Company
3.1.1 Global Dolutegravir Annual Sales by Company (2018-2023)
3.1.2 Global Dolutegravir Sales Market Share by Company (2018-2023)
3.2 Global Dolutegravir Annual Revenue by Company (2018-2023)
3.2.1 Global Dolutegravir Revenue by Company (2018-2023)
3.2.2 Global Dolutegravir Revenue Market Share by Company (2018-2023)
3.3 Global Dolutegravir Sale Price by Company
3.4 Key Manufacturers Dolutegravir Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Dolutegravir Product Location Distribution
3.4.2 Players Dolutegravir Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR DOLUTEGRAVIR BY GEOGRAPHIC REGION
4.1 World Historic Dolutegravir Market Size by Geographic Region (2018-2023)
4.1.1 Global Dolutegravir Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Dolutegravir Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Dolutegravir Market Size by Country/Region (2018-2023)
4.2.1 Global Dolutegravir Annual Sales by Country/Region (2018-2023)
4.2.2 Global Dolutegravir Annual Revenue by Country/Region (2018-2023)
4.3 Americas Dolutegravir Sales Growth
4.4 APAC Dolutegravir Sales Growth
4.5 Europe Dolutegravir Sales Growth
4.6 Middle East & Africa Dolutegravir Sales Growth
5 AMERICAS
5.1 Americas Dolutegravir Sales by Country
5.1.1 Americas Dolutegravir Sales by Country (2018-2023)
5.1.2 Americas Dolutegravir Revenue by Country (2018-2023)
5.2 Americas Dolutegravir Sales by Type
5.3 Americas Dolutegravir Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dolutegravir Sales by Region
6.1.1 APAC Dolutegravir Sales by Region (2018-2023)
6.1.2 APAC Dolutegravir Revenue by Region (2018-2023)
6.2 APAC Dolutegravir Sales by Type
6.3 APAC Dolutegravir Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Dolutegravir by Country
7.1.1 Europe Dolutegravir Sales by Country (2018-2023)
7.1.2 Europe Dolutegravir Revenue by Country (2018-2023)
7.2 Europe Dolutegravir Sales by Type
7.3 Europe Dolutegravir Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Dolutegravir by Country
8.1.1 Middle East & Africa Dolutegravir Sales by Country (2018-2023)
8.1.2 Middle East & Africa Dolutegravir Revenue by Country (2018-2023)
8.2 Middle East & Africa Dolutegravir Sales by Type
8.3 Middle East & Africa Dolutegravir Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Dolutegravir
10.3 Manufacturing Process Analysis of Dolutegravir
10.4 Industry Chain Structure of Dolutegravir
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Dolutegravir Distributors
11.3 Dolutegravir Customer
12 WORLD FORECAST REVIEW FOR DOLUTEGRAVIR BY GEOGRAPHIC REGION
12.1 Global Dolutegravir Market Size Forecast by Region
12.1.1 Global Dolutegravir Forecast by Region (2024-2029)
12.1.2 Global Dolutegravir Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Dolutegravir Forecast by Type
12.7 Global Dolutegravir Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 ViiV Healthcare (GSK)
13.1.1 ViiV Healthcare (GSK) Company Information
13.1.2 ViiV Healthcare (GSK) Dolutegravir Product Portfolios and Specifications
13.1.3 ViiV Healthcare (GSK) Dolutegravir Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 ViiV Healthcare (GSK) Main Business Overview
13.1.5 ViiV Healthcare (GSK) Latest Developments
13.2 Shanghai Desano Pharmaceuticals
13.2.1 Shanghai Desano Pharmaceuticals Company Information
13.2.2 Shanghai Desano Pharmaceuticals Dolutegravir Product Portfolios and Specifications
13.2.3 Shanghai Desano Pharmaceuticals Dolutegravir Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Shanghai Desano Pharmaceuticals Main Business Overview
13.2.5 Shanghai Desano Pharmaceuticals Latest Developments
13.3 Mylan
13.3.1 Mylan Company Information
13.3.2 Mylan Dolutegravir Product Portfolios and Specifications
13.3.3 Mylan Dolutegravir Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Mylan Main Business Overview
13.3.5 Mylan Latest Developments
13.4 Aurobindo Pharma
13.4.1 Aurobindo Pharma Company Information
13.4.2 Aurobindo Pharma Dolutegravir Product Portfolios and Specifications
13.4.3 Aurobindo Pharma Dolutegravir Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Aurobindo Pharma Main Business Overview
13.4.5 Aurobindo Pharma Latest Developments
13.5 LAURUS Labs
13.5.1 LAURUS Labs Company Information
13.5.2 LAURUS Labs Dolutegravir Product Portfolios and Specifications
13.5.3 LAURUS Labs Dolutegravir Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 LAURUS Labs Main Business Overview
13.5.5 LAURUS Labs Latest Developments
13.6 Adcock Ingram Limited
13.6.1 Adcock Ingram Limited Company Information
13.6.2 Adcock Ingram Limited Dolutegravir Product Portfolios and Specifications
13.6.3 Adcock Ingram Limited Dolutegravir Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Adcock Ingram Limited Main Business Overview
13.6.5 Adcock Ingram Limited Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Dolutegravir Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Dolutegravir by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Dolutegravir by Country/Region, 2018, 2022 & 2029
2.2 Dolutegravir Segment by Type
2.2.1 10mg Tablets
2.2.2 50mg Tablets
2.3 Dolutegravir Sales by Type
2.3.1 Global Dolutegravir Sales Market Share by Type (2018-2023)
2.3.2 Global Dolutegravir Revenue and Market Share by Type (2018-2023)
2.3.3 Global Dolutegravir Sale Price by Type (2018-2023)
2.4 Dolutegravir Segment by Application
2.4.1 Prevent HIV Infection Following Potential Exposure
2.4.2 Other
2.5 Dolutegravir Sales by Application
2.5.1 Global Dolutegravir Sale Market Share by Application (2018-2023)
2.5.2 Global Dolutegravir Revenue and Market Share by Application (2018-2023)
2.5.3 Global Dolutegravir Sale Price by Application (2018-2023)
3 GLOBAL DOLUTEGRAVIR BY COMPANY
3.1 Global Dolutegravir Breakdown Data by Company
3.1.1 Global Dolutegravir Annual Sales by Company (2018-2023)
3.1.2 Global Dolutegravir Sales Market Share by Company (2018-2023)
3.2 Global Dolutegravir Annual Revenue by Company (2018-2023)
3.2.1 Global Dolutegravir Revenue by Company (2018-2023)
3.2.2 Global Dolutegravir Revenue Market Share by Company (2018-2023)
3.3 Global Dolutegravir Sale Price by Company
3.4 Key Manufacturers Dolutegravir Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Dolutegravir Product Location Distribution
3.4.2 Players Dolutegravir Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR DOLUTEGRAVIR BY GEOGRAPHIC REGION
4.1 World Historic Dolutegravir Market Size by Geographic Region (2018-2023)
4.1.1 Global Dolutegravir Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Dolutegravir Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Dolutegravir Market Size by Country/Region (2018-2023)
4.2.1 Global Dolutegravir Annual Sales by Country/Region (2018-2023)
4.2.2 Global Dolutegravir Annual Revenue by Country/Region (2018-2023)
4.3 Americas Dolutegravir Sales Growth
4.4 APAC Dolutegravir Sales Growth
4.5 Europe Dolutegravir Sales Growth
4.6 Middle East & Africa Dolutegravir Sales Growth
5 AMERICAS
5.1 Americas Dolutegravir Sales by Country
5.1.1 Americas Dolutegravir Sales by Country (2018-2023)
5.1.2 Americas Dolutegravir Revenue by Country (2018-2023)
5.2 Americas Dolutegravir Sales by Type
5.3 Americas Dolutegravir Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Dolutegravir Sales by Region
6.1.1 APAC Dolutegravir Sales by Region (2018-2023)
6.1.2 APAC Dolutegravir Revenue by Region (2018-2023)
6.2 APAC Dolutegravir Sales by Type
6.3 APAC Dolutegravir Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Dolutegravir by Country
7.1.1 Europe Dolutegravir Sales by Country (2018-2023)
7.1.2 Europe Dolutegravir Revenue by Country (2018-2023)
7.2 Europe Dolutegravir Sales by Type
7.3 Europe Dolutegravir Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Dolutegravir by Country
8.1.1 Middle East & Africa Dolutegravir Sales by Country (2018-2023)
8.1.2 Middle East & Africa Dolutegravir Revenue by Country (2018-2023)
8.2 Middle East & Africa Dolutegravir Sales by Type
8.3 Middle East & Africa Dolutegravir Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Dolutegravir
10.3 Manufacturing Process Analysis of Dolutegravir
10.4 Industry Chain Structure of Dolutegravir
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Dolutegravir Distributors
11.3 Dolutegravir Customer
12 WORLD FORECAST REVIEW FOR DOLUTEGRAVIR BY GEOGRAPHIC REGION
12.1 Global Dolutegravir Market Size Forecast by Region
12.1.1 Global Dolutegravir Forecast by Region (2024-2029)
12.1.2 Global Dolutegravir Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Dolutegravir Forecast by Type
12.7 Global Dolutegravir Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 ViiV Healthcare (GSK)
13.1.1 ViiV Healthcare (GSK) Company Information
13.1.2 ViiV Healthcare (GSK) Dolutegravir Product Portfolios and Specifications
13.1.3 ViiV Healthcare (GSK) Dolutegravir Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 ViiV Healthcare (GSK) Main Business Overview
13.1.5 ViiV Healthcare (GSK) Latest Developments
13.2 Shanghai Desano Pharmaceuticals
13.2.1 Shanghai Desano Pharmaceuticals Company Information
13.2.2 Shanghai Desano Pharmaceuticals Dolutegravir Product Portfolios and Specifications
13.2.3 Shanghai Desano Pharmaceuticals Dolutegravir Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Shanghai Desano Pharmaceuticals Main Business Overview
13.2.5 Shanghai Desano Pharmaceuticals Latest Developments
13.3 Mylan
13.3.1 Mylan Company Information
13.3.2 Mylan Dolutegravir Product Portfolios and Specifications
13.3.3 Mylan Dolutegravir Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Mylan Main Business Overview
13.3.5 Mylan Latest Developments
13.4 Aurobindo Pharma
13.4.1 Aurobindo Pharma Company Information
13.4.2 Aurobindo Pharma Dolutegravir Product Portfolios and Specifications
13.4.3 Aurobindo Pharma Dolutegravir Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Aurobindo Pharma Main Business Overview
13.4.5 Aurobindo Pharma Latest Developments
13.5 LAURUS Labs
13.5.1 LAURUS Labs Company Information
13.5.2 LAURUS Labs Dolutegravir Product Portfolios and Specifications
13.5.3 LAURUS Labs Dolutegravir Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 LAURUS Labs Main Business Overview
13.5.5 LAURUS Labs Latest Developments
13.6 Adcock Ingram Limited
13.6.1 Adcock Ingram Limited Company Information
13.6.2 Adcock Ingram Limited Dolutegravir Product Portfolios and Specifications
13.6.3 Adcock Ingram Limited Dolutegravir Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Adcock Ingram Limited Main Business Overview
13.6.5 Adcock Ingram Limited Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Dolutegravir Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Dolutegravir Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 10mg Tablets
Table 4. Major Players of 50mg Tablets
Table 5. Global Dolutegravir Sales by Type (2018-2023) & (K Pcs)
Table 6. Global Dolutegravir Sales Market Share by Type (2018-2023)
Table 7. Global Dolutegravir Revenue by Type (2018-2023) & ($ million)
Table 8. Global Dolutegravir Revenue Market Share by Type (2018-2023)
Table 9. Global Dolutegravir Sale Price by Type (2018-2023) & (USD/Pcs)
Table 10. Global Dolutegravir Sales by Application (2018-2023) & (K Pcs)
Table 11. Global Dolutegravir Sales Market Share by Application (2018-2023)
Table 12. Global Dolutegravir Revenue by Application (2018-2023)
Table 13. Global Dolutegravir Revenue Market Share by Application (2018-2023)
Table 14. Global Dolutegravir Sale Price by Application (2018-2023) & (USD/Pcs)
Table 15. Global Dolutegravir Sales by Company (2018-2023) & (K Pcs)
Table 16. Global Dolutegravir Sales Market Share by Company (2018-2023)
Table 17. Global Dolutegravir Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Dolutegravir Revenue Market Share by Company (2018-2023)
Table 19. Global Dolutegravir Sale Price by Company (2018-2023) & (USD/Pcs)
Table 20. Key Manufacturers Dolutegravir Producing Area Distribution and Sales Area
Table 21. Players Dolutegravir Products Offered
Table 22. Dolutegravir Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Dolutegravir Sales by Geographic Region (2018-2023) & (K Pcs)
Table 26. Global Dolutegravir Sales Market Share Geographic Region (2018-2023)
Table 27. Global Dolutegravir Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Dolutegravir Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Dolutegravir Sales by Country/Region (2018-2023) & (K Pcs)
Table 30. Global Dolutegravir Sales Market Share by Country/Region (2018-2023)
Table 31. Global Dolutegravir Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Dolutegravir Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Dolutegravir Sales by Country (2018-2023) & (K Pcs)
Table 34. Americas Dolutegravir Sales Market Share by Country (2018-2023)
Table 35. Americas Dolutegravir Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Dolutegravir Revenue Market Share by Country (2018-2023)
Table 37. Americas Dolutegravir Sales by Type (2018-2023) & (K Pcs)
Table 38. Americas Dolutegravir Sales by Application (2018-2023) & (K Pcs)
Table 39. APAC Dolutegravir Sales by Region (2018-2023) & (K Pcs)
Table 40. APAC Dolutegravir Sales Market Share by Region (2018-2023)
Table 41. APAC Dolutegravir Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Dolutegravir Revenue Market Share by Region (2018-2023)
Table 43. APAC Dolutegravir Sales by Type (2018-2023) & (K Pcs)
Table 44. APAC Dolutegravir Sales by Application (2018-2023) & (K Pcs)
Table 45. Europe Dolutegravir Sales by Country (2018-2023) & (K Pcs)
Table 46. Europe Dolutegravir Sales Market Share by Country (2018-2023)
Table 47. Europe Dolutegravir Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Dolutegravir Revenue Market Share by Country (2018-2023)
Table 49. Europe Dolutegravir Sales by Type (2018-2023) & (K Pcs)
Table 50. Europe Dolutegravir Sales by Application (2018-2023) & (K Pcs)
Table 51. Middle East & Africa Dolutegravir Sales by Country (2018-2023) & (K Pcs)
Table 52. Middle East & Africa Dolutegravir Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Dolutegravir Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Dolutegravir Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Dolutegravir Sales by Type (2018-2023) & (K Pcs)
Table 56. Middle East & Africa Dolutegravir Sales by Application (2018-2023) & (K Pcs)
Table 57. Key Market Drivers & Growth Opportunities of Dolutegravir
Table 58. Key Market Challenges & Risks of Dolutegravir
Table 59. Key Industry Trends of Dolutegravir
Table 60. Dolutegravir Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Dolutegravir Distributors List
Table 63. Dolutegravir Customer List
Table 64. Global Dolutegravir Sales Forecast by Region (2024-2029) & (K Pcs)
Table 65. Global Dolutegravir Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Dolutegravir Sales Forecast by Country (2024-2029) & (K Pcs)
Table 67. Americas Dolutegravir Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Dolutegravir Sales Forecast by Region (2024-2029) & (K Pcs)
Table 69. APAC Dolutegravir Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Dolutegravir Sales Forecast by Country (2024-2029) & (K Pcs)
Table 71. Europe Dolutegravir Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Dolutegravir Sales Forecast by Country (2024-2029) & (K Pcs)
Table 73. Middle East & Africa Dolutegravir Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Dolutegravir Sales Forecast by Type (2024-2029) & (K Pcs)
Table 75. Global Dolutegravir Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Dolutegravir Sales Forecast by Application (2024-2029) & (K Pcs)
Table 77. Global Dolutegravir Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. ViiV Healthcare (GSK) Basic Information, Dolutegravir Manufacturing Base, Sales Area and Its Competitors
Table 79. ViiV Healthcare (GSK) Dolutegravir Product Portfolios and Specifications
Table 80. ViiV Healthcare (GSK) Dolutegravir Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 81. ViiV Healthcare (GSK) Main Business
Table 82. ViiV Healthcare (GSK) Latest Developments
Table 83. Shanghai Desano Pharmaceuticals Basic Information, Dolutegravir Manufacturing Base, Sales Area and Its Competitors
Table 84. Shanghai Desano Pharmaceuticals Dolutegravir Product Portfolios and Specifications
Table 85. Shanghai Desano Pharmaceuticals Dolutegravir Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 86. Shanghai Desano Pharmaceuticals Main Business
Table 87. Shanghai Desano Pharmaceuticals Latest Developments
Table 88. Mylan Basic Information, Dolutegravir Manufacturing Base, Sales Area and Its Competitors
Table 89. Mylan Dolutegravir Product Portfolios and Specifications
Table 90. Mylan Dolutegravir Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 91. Mylan Main Business
Table 92. Mylan Latest Developments
Table 93. Aurobindo Pharma Basic Information, Dolutegravir Manufacturing Base, Sales Area and Its Competitors
Table 94. Aurobindo Pharma Dolutegravir Product Portfolios and Specifications
Table 95. Aurobindo Pharma Dolutegravir Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 96. Aurobindo Pharma Main Business
Table 97. Aurobindo Pharma Latest Developments
Table 98. LAURUS Labs Basic Information, Dolutegravir Manufacturing Base, Sales Area and Its Competitors
Table 99. LAURUS Labs Dolutegravir Product Portfolios and Specifications
Table 100. LAURUS Labs Dolutegravir Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 101. LAURUS Labs Main Business
Table 102. LAURUS Labs Latest Developments
Table 103. Adcock Ingram Limited Basic Information, Dolutegravir Manufacturing Base, Sales Area and Its Competitors
Table 104. Adcock Ingram Limited Dolutegravir Product Portfolios and Specifications
Table 105. Adcock Ingram Limited Dolutegravir Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 106. Adcock Ingram Limited Main Business
Table 107. Adcock Ingram Limited Latest Developments
Table 1. Dolutegravir Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Dolutegravir Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 10mg Tablets
Table 4. Major Players of 50mg Tablets
Table 5. Global Dolutegravir Sales by Type (2018-2023) & (K Pcs)
Table 6. Global Dolutegravir Sales Market Share by Type (2018-2023)
Table 7. Global Dolutegravir Revenue by Type (2018-2023) & ($ million)
Table 8. Global Dolutegravir Revenue Market Share by Type (2018-2023)
Table 9. Global Dolutegravir Sale Price by Type (2018-2023) & (USD/Pcs)
Table 10. Global Dolutegravir Sales by Application (2018-2023) & (K Pcs)
Table 11. Global Dolutegravir Sales Market Share by Application (2018-2023)
Table 12. Global Dolutegravir Revenue by Application (2018-2023)
Table 13. Global Dolutegravir Revenue Market Share by Application (2018-2023)
Table 14. Global Dolutegravir Sale Price by Application (2018-2023) & (USD/Pcs)
Table 15. Global Dolutegravir Sales by Company (2018-2023) & (K Pcs)
Table 16. Global Dolutegravir Sales Market Share by Company (2018-2023)
Table 17. Global Dolutegravir Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Dolutegravir Revenue Market Share by Company (2018-2023)
Table 19. Global Dolutegravir Sale Price by Company (2018-2023) & (USD/Pcs)
Table 20. Key Manufacturers Dolutegravir Producing Area Distribution and Sales Area
Table 21. Players Dolutegravir Products Offered
Table 22. Dolutegravir Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Dolutegravir Sales by Geographic Region (2018-2023) & (K Pcs)
Table 26. Global Dolutegravir Sales Market Share Geographic Region (2018-2023)
Table 27. Global Dolutegravir Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Dolutegravir Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Dolutegravir Sales by Country/Region (2018-2023) & (K Pcs)
Table 30. Global Dolutegravir Sales Market Share by Country/Region (2018-2023)
Table 31. Global Dolutegravir Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Dolutegravir Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Dolutegravir Sales by Country (2018-2023) & (K Pcs)
Table 34. Americas Dolutegravir Sales Market Share by Country (2018-2023)
Table 35. Americas Dolutegravir Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Dolutegravir Revenue Market Share by Country (2018-2023)
Table 37. Americas Dolutegravir Sales by Type (2018-2023) & (K Pcs)
Table 38. Americas Dolutegravir Sales by Application (2018-2023) & (K Pcs)
Table 39. APAC Dolutegravir Sales by Region (2018-2023) & (K Pcs)
Table 40. APAC Dolutegravir Sales Market Share by Region (2018-2023)
Table 41. APAC Dolutegravir Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Dolutegravir Revenue Market Share by Region (2018-2023)
Table 43. APAC Dolutegravir Sales by Type (2018-2023) & (K Pcs)
Table 44. APAC Dolutegravir Sales by Application (2018-2023) & (K Pcs)
Table 45. Europe Dolutegravir Sales by Country (2018-2023) & (K Pcs)
Table 46. Europe Dolutegravir Sales Market Share by Country (2018-2023)
Table 47. Europe Dolutegravir Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Dolutegravir Revenue Market Share by Country (2018-2023)
Table 49. Europe Dolutegravir Sales by Type (2018-2023) & (K Pcs)
Table 50. Europe Dolutegravir Sales by Application (2018-2023) & (K Pcs)
Table 51. Middle East & Africa Dolutegravir Sales by Country (2018-2023) & (K Pcs)
Table 52. Middle East & Africa Dolutegravir Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Dolutegravir Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Dolutegravir Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Dolutegravir Sales by Type (2018-2023) & (K Pcs)
Table 56. Middle East & Africa Dolutegravir Sales by Application (2018-2023) & (K Pcs)
Table 57. Key Market Drivers & Growth Opportunities of Dolutegravir
Table 58. Key Market Challenges & Risks of Dolutegravir
Table 59. Key Industry Trends of Dolutegravir
Table 60. Dolutegravir Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Dolutegravir Distributors List
Table 63. Dolutegravir Customer List
Table 64. Global Dolutegravir Sales Forecast by Region (2024-2029) & (K Pcs)
Table 65. Global Dolutegravir Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Dolutegravir Sales Forecast by Country (2024-2029) & (K Pcs)
Table 67. Americas Dolutegravir Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Dolutegravir Sales Forecast by Region (2024-2029) & (K Pcs)
Table 69. APAC Dolutegravir Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Dolutegravir Sales Forecast by Country (2024-2029) & (K Pcs)
Table 71. Europe Dolutegravir Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Dolutegravir Sales Forecast by Country (2024-2029) & (K Pcs)
Table 73. Middle East & Africa Dolutegravir Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Dolutegravir Sales Forecast by Type (2024-2029) & (K Pcs)
Table 75. Global Dolutegravir Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Dolutegravir Sales Forecast by Application (2024-2029) & (K Pcs)
Table 77. Global Dolutegravir Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. ViiV Healthcare (GSK) Basic Information, Dolutegravir Manufacturing Base, Sales Area and Its Competitors
Table 79. ViiV Healthcare (GSK) Dolutegravir Product Portfolios and Specifications
Table 80. ViiV Healthcare (GSK) Dolutegravir Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 81. ViiV Healthcare (GSK) Main Business
Table 82. ViiV Healthcare (GSK) Latest Developments
Table 83. Shanghai Desano Pharmaceuticals Basic Information, Dolutegravir Manufacturing Base, Sales Area and Its Competitors
Table 84. Shanghai Desano Pharmaceuticals Dolutegravir Product Portfolios and Specifications
Table 85. Shanghai Desano Pharmaceuticals Dolutegravir Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 86. Shanghai Desano Pharmaceuticals Main Business
Table 87. Shanghai Desano Pharmaceuticals Latest Developments
Table 88. Mylan Basic Information, Dolutegravir Manufacturing Base, Sales Area and Its Competitors
Table 89. Mylan Dolutegravir Product Portfolios and Specifications
Table 90. Mylan Dolutegravir Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 91. Mylan Main Business
Table 92. Mylan Latest Developments
Table 93. Aurobindo Pharma Basic Information, Dolutegravir Manufacturing Base, Sales Area and Its Competitors
Table 94. Aurobindo Pharma Dolutegravir Product Portfolios and Specifications
Table 95. Aurobindo Pharma Dolutegravir Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 96. Aurobindo Pharma Main Business
Table 97. Aurobindo Pharma Latest Developments
Table 98. LAURUS Labs Basic Information, Dolutegravir Manufacturing Base, Sales Area and Its Competitors
Table 99. LAURUS Labs Dolutegravir Product Portfolios and Specifications
Table 100. LAURUS Labs Dolutegravir Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 101. LAURUS Labs Main Business
Table 102. LAURUS Labs Latest Developments
Table 103. Adcock Ingram Limited Basic Information, Dolutegravir Manufacturing Base, Sales Area and Its Competitors
Table 104. Adcock Ingram Limited Dolutegravir Product Portfolios and Specifications
Table 105. Adcock Ingram Limited Dolutegravir Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 106. Adcock Ingram Limited Main Business
Table 107. Adcock Ingram Limited Latest Developments
LIST OF FIGURES
Figure 1. Picture of Dolutegravir
Figure 2. Dolutegravir Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dolutegravir Sales Growth Rate 2018-2029 (K Pcs)
Figure 7. Global Dolutegravir Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Dolutegravir Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 10mg Tablets
Figure 10. Product Picture of 50mg Tablets
Figure 11. Global Dolutegravir Sales Market Share by Type in 2022
Figure 12. Global Dolutegravir Revenue Market Share by Type (2018-2023)
Figure 13. Dolutegravir Consumed in Prevent HIV Infection Following Potential Exposure
Figure 14. Global Dolutegravir Market: Prevent HIV Infection Following Potential Exposure (2018-2023) & (K Pcs)
Figure 15. Dolutegravir Consumed in Other
Figure 16. Global Dolutegravir Market: Other (2018-2023) & (K Pcs)
Figure 17. Global Dolutegravir Sales Market Share by Application (2022)
Figure 18. Global Dolutegravir Revenue Market Share by Application in 2022
Figure 19. Dolutegravir Sales Market by Company in 2022 (K Pcs)
Figure 20. Global Dolutegravir Sales Market Share by Company in 2022
Figure 21. Dolutegravir Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Dolutegravir Revenue Market Share by Company in 2022
Figure 23. Global Dolutegravir Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Dolutegravir Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Dolutegravir Sales 2018-2023 (K Pcs)
Figure 26. Americas Dolutegravir Revenue 2018-2023 ($ Millions)
Figure 27. APAC Dolutegravir Sales 2018-2023 (K Pcs)
Figure 28. APAC Dolutegravir Revenue 2018-2023 ($ Millions)
Figure 29. Europe Dolutegravir Sales 2018-2023 (K Pcs)
Figure 30. Europe Dolutegravir Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Dolutegravir Sales 2018-2023 (K Pcs)
Figure 32. Middle East & Africa Dolutegravir Revenue 2018-2023 ($ Millions)
Figure 33. Americas Dolutegravir Sales Market Share by Country in 2022
Figure 34. Americas Dolutegravir Revenue Market Share by Country in 2022
Figure 35. Americas Dolutegravir Sales Market Share by Type (2018-2023)
Figure 36. Americas Dolutegravir Sales Market Share by Application (2018-2023)
Figure 37. United States Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Dolutegravir Sales Market Share by Region in 2022
Figure 42. APAC Dolutegravir Revenue Market Share by Regions in 2022
Figure 43. APAC Dolutegravir Sales Market Share by Type (2018-2023)
Figure 44. APAC Dolutegravir Sales Market Share by Application (2018-2023)
Figure 45. China Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Dolutegravir Sales Market Share by Country in 2022
Figure 53. Europe Dolutegravir Revenue Market Share by Country in 2022
Figure 54. Europe Dolutegravir Sales Market Share by Type (2018-2023)
Figure 55. Europe Dolutegravir Sales Market Share by Application (2018-2023)
Figure 56. Germany Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Dolutegravir Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Dolutegravir Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Dolutegravir Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Dolutegravir Sales Market Share by Application (2018-2023)
Figure 65. Egypt Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Dolutegravir in 2022
Figure 71. Manufacturing Process Analysis of Dolutegravir
Figure 72. Industry Chain Structure of Dolutegravir
Figure 73. Channels of Distribution
Figure 74. Global Dolutegravir Sales Market Forecast by Region (2024-2029)
Figure 75. Global Dolutegravir Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Dolutegravir Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Dolutegravir Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Dolutegravir Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Dolutegravir Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Dolutegravir
Figure 2. Dolutegravir Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Dolutegravir Sales Growth Rate 2018-2029 (K Pcs)
Figure 7. Global Dolutegravir Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Dolutegravir Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 10mg Tablets
Figure 10. Product Picture of 50mg Tablets
Figure 11. Global Dolutegravir Sales Market Share by Type in 2022
Figure 12. Global Dolutegravir Revenue Market Share by Type (2018-2023)
Figure 13. Dolutegravir Consumed in Prevent HIV Infection Following Potential Exposure
Figure 14. Global Dolutegravir Market: Prevent HIV Infection Following Potential Exposure (2018-2023) & (K Pcs)
Figure 15. Dolutegravir Consumed in Other
Figure 16. Global Dolutegravir Market: Other (2018-2023) & (K Pcs)
Figure 17. Global Dolutegravir Sales Market Share by Application (2022)
Figure 18. Global Dolutegravir Revenue Market Share by Application in 2022
Figure 19. Dolutegravir Sales Market by Company in 2022 (K Pcs)
Figure 20. Global Dolutegravir Sales Market Share by Company in 2022
Figure 21. Dolutegravir Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Dolutegravir Revenue Market Share by Company in 2022
Figure 23. Global Dolutegravir Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Dolutegravir Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Dolutegravir Sales 2018-2023 (K Pcs)
Figure 26. Americas Dolutegravir Revenue 2018-2023 ($ Millions)
Figure 27. APAC Dolutegravir Sales 2018-2023 (K Pcs)
Figure 28. APAC Dolutegravir Revenue 2018-2023 ($ Millions)
Figure 29. Europe Dolutegravir Sales 2018-2023 (K Pcs)
Figure 30. Europe Dolutegravir Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Dolutegravir Sales 2018-2023 (K Pcs)
Figure 32. Middle East & Africa Dolutegravir Revenue 2018-2023 ($ Millions)
Figure 33. Americas Dolutegravir Sales Market Share by Country in 2022
Figure 34. Americas Dolutegravir Revenue Market Share by Country in 2022
Figure 35. Americas Dolutegravir Sales Market Share by Type (2018-2023)
Figure 36. Americas Dolutegravir Sales Market Share by Application (2018-2023)
Figure 37. United States Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Dolutegravir Sales Market Share by Region in 2022
Figure 42. APAC Dolutegravir Revenue Market Share by Regions in 2022
Figure 43. APAC Dolutegravir Sales Market Share by Type (2018-2023)
Figure 44. APAC Dolutegravir Sales Market Share by Application (2018-2023)
Figure 45. China Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Dolutegravir Sales Market Share by Country in 2022
Figure 53. Europe Dolutegravir Revenue Market Share by Country in 2022
Figure 54. Europe Dolutegravir Sales Market Share by Type (2018-2023)
Figure 55. Europe Dolutegravir Sales Market Share by Application (2018-2023)
Figure 56. Germany Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Dolutegravir Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Dolutegravir Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Dolutegravir Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Dolutegravir Sales Market Share by Application (2018-2023)
Figure 65. Egypt Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Dolutegravir Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Dolutegravir in 2022
Figure 71. Manufacturing Process Analysis of Dolutegravir
Figure 72. Industry Chain Structure of Dolutegravir
Figure 73. Channels of Distribution
Figure 74. Global Dolutegravir Sales Market Forecast by Region (2024-2029)
Figure 75. Global Dolutegravir Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Dolutegravir Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Dolutegravir Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Dolutegravir Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Dolutegravir Revenue Market Share Forecast by Application (2024-2029)
